U.S. House · 117th Congress · H.R. 597
Pandemic Treatment Access and Affordability Act of 2021
To require any COVID-19 drug developed in whole or in part with Federal support to be affordable and accessible by prohibiting monopolies and price gouging, and for other purposes.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Janice D. SchakowskyD-IL-9
- Introduced
- January 28, 2021, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (26)
26 Democrats. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Sanford D. Bishop, Jr.D-GA-2
- Judy ChuD-CA-27
- Peter A. DeFazioD-OR-4
- Rosa L. DeLauroD-CT-3
- Lloyd DoggettD-TX-35
- Raúl M. GrijalvaD-AZ-3
- Pramila JayapalD-WA-7
- Ro KhannaD-CA-17
- Betty McCollumD-MN-4
- Eleanor Holmes NortonD-DC-AL
- Chellie PingreeD-ME-1
- Mark PocanD-WI-2
- Jamie RaskinD-MD-8
- Peter WelchD-VT-AL
Signed on later
- André CarsonD-IN-7February 22, 2021
- Mark DeSaulnierD-CA-11February 22, 2021
- Dwight EvansD-PA-3February 22, 2021
- Alcee L. HastingsD-FL-20February 22, 2021
- Michael F. Q. San NicolasD-GU-ALFebruary 22, 2021
- Al Lawson, Jr.D-FL-5February 23, 2021
- Mary Gay ScanlonD-PA-5February 23, 2021
- Dina TitusD-NV-1February 23, 2021
- Steve CohenD-TN-9March 26, 2021
- Jahana HayesD-CT-5March 26, 2021
- David E. PriceD-NC-4May 4, 2021
- Bennie G. ThompsonD-MS-2May 28, 2021